Alloy Therapeutics Inc. ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

Alloy Therapeutics Inc., a biotechnology ecosystem company, has joined forces with Pfizer Inc., to develop a new platform ...

Privately-held Alloy Therapeutics has announced a new multi-year collaboration with Pfizer to develop a bespoke platform that ...

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

Pfizer (NYSE:PFE) has entered into a multi-year collaboration with Alloy Therapeutics to develop a new antibody discovery platform. Under the deal, Alloy will receive an upfront payment from Pfizer ...

Boston: Alloy Therapeutics Inc., a biotechnology ecosystem company has announced its latest strategic collaboration with ...

Smith System, a global leader in driver safety management, has acquired Brightmile, a cutting-edge driver behavior analytics solution. This strategic acquisition enhances Smith System's ability to ...

Tempus AI, Inc. , a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, February 24, 2025.

The Series B round was co-led by Samsara BioCapital and Enavate Sciences, with participation from Pfizer Ventures ... supported by its collaboration with Alloy Therapeutics to develop precision ...

With a forward P/E ratio of 5.79 and a PEG ratio of 0.05, BioNTech played a huge part in formulating the BioNTech-Pfizer vaccine ... supplies ferro-alloys; along with processes ferrous and ...

The Series B round was co-led by Samsara BioCapital and Enavate Sciences, with participation from Pfizer Ventures ... s trajectory is further supported by its collaboration with Alloy Therapeutics to ...

NEW YORK, Feb 3 (Reuters) - Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could put additional pressure on Pfizer (PFE.N ...